{"id":"W4247879458","doi":"10.1200/jco.2017.35.15_suppl.lba3","title":"LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Abiraterone acetate; Medicine; Prostate cancer; Androgen deprivation therapy; Prednisone; Internal medicine; Abiraterone; Oncology; Clinical trial; Family medicine; Cancer; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007332507,0.001374779,0.002000126,0.0004899449,0.0004592691,0.001086359,0.0007091816,0.001095972,0.01078725],"category_scores_gemma":[0.001246989,0.0006058147,0.001325871,0.0003799887,0.0008953106,0.001025213,0.0004372926,0.00237408,0.002108287],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004226468,"about_ca_system_score_gemma":0.001059504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001009932,"about_ca_topic_score_gemma":0.003408354,"domain_scores_codex":[0.9996459,0.0002003836,0.0000257951,0.00004779736,0.00003259693,0.00004745368],"domain_scores_gemma":[0.9994785,0.0001376165,0.0001316957,0.00003890122,0.00002823514,0.0001850524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.971448,0.00359519,0.0002895515,0.001126001,0.0008998194,0.00002918254,0.00004155368,0.0002641611,0.002683367,0.0001529553,0.00162913,0.01784108],"study_design_scores_gemma":[0.9674001,0.03018178,0.0006831298,0.00003772144,0.0003045178,0.00002752739,0.00002980181,0.0001668894,0.0002088994,0.0001240984,0.0008234462,0.00001213009],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9552495,0.02208564,0.001287526,0.001900756,0.00260852,0.004487008,0.002909352,0.0005869883,0.008884746],"genre_scores_gemma":[0.9653197,0.01165941,0.001869634,0.002226275,0.001463695,0.006127471,0.002182787,0.00006344839,0.009087666],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01078725,"threshold_uncertainty_score":0.03608692,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1856420401604156,"score_gpt":0.5032530866104884,"score_spread":0.3176110464500728,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}